Bonus Material-15_Faiz, Pleural Disease I

Pdf Summary

This 2025 CHEST Board Review by Dr. Saadia Faiz covers pleural diseases, focusing on pleural fluid physiology, analysis, pneumothorax types, imaging, and management. Pleural diseases represent 5% of chest pathology, including fibrosis, pneumothorax, and effusions (transudative vs. exudative). Infections comprise 12%, and neoplasia 9.5%, notably mesothelioma and malignant effusions.<br /><br />Pleural fluid (~0.26 mL/kg/cavity) is produced and absorbed via parietal pleura, maintained by hydrostatic and oncotic pressures. Mortality in pleural effusions varies: malignant effusions carry one-year mortality up to 77%; non-malignant effusions also show high mortality, reflecting underlying disease severity.<br /><br />Pleural fluid analysis is crucial, examining appearance (e.g., milky for chylothorax), chemistry (protein, LDH, glucose, amylase), cell counts (neutrophils, lymphocytes, eosinophils), and microbiology/cytology. Light’s criteria differentiate exudates from transudates but may misclassify ~25% transudates, especially in heart failure patients on diuretics. Additional tests—pleural fluid to serum albumin, NT-proBNP—are helpful. Low pH and glucose indicate empyema, malignancy, or rheumatoid pleuritis.<br /><br />Common transudate causes include heart failure, hepatic hydrothorax (5% cirrhotics), nephrotic syndrome, urinothorax, and peritoneal dialysis-associated effusions. Exudates arise from infection, inflammation, malignancy, and trauma. Chylothorax diagnosis relies on triglycerides >110 mg/dL and chylomicrons; pseudochylothorax has high cholesterol without chylomicrons.<br /><br />Imaging modalities include chest X-ray (lateral, decubitus), CT showing pleural disease versus masses, and point-of-care ultrasound (POCUS) for fluid detection and pneumothorax confirmation. Lung sliding sign absence suggests pneumothorax.<br /><br />Pneumothorax classifications include primary spontaneous (young, no lung disease), secondary spontaneous (underlying lung disease), traumatic, and iatrogenic. Management depends on size, symptoms, and patient stability, ranging from observation, needle aspiration, chest tube insertion, ambulatory devices, to surgery. Recent trials show conservative management of first-time PSP may be noninferior, with fewer adverse effects.<br /><br />Pleural interventions involve thoracentesis, chest tubes, indwelling pleural catheters, and medical thoracoscopy, all with risks including infection, bleeding, and re-expansion pulmonary edema—a rare but serious complication after rapid drainage.<br /><br />In summary, effective management requires understanding pleural fluid physiology and analysis, integrating clinical, imaging, and procedural knowledge to treat pneumothorax and pleural effusions safely.

Meta Tag

Concept Pleural Fluid

Concept Pleural Effusion

Concept Pleural Fluid Analysis

Concept Pneumothorax

Concept Tension Pneumothorax

Keywords

pleural disease

pleural fluid analysis

Light's criteria

transudative effusion

exudative effusion

pneumothorax

chylothorax

thoracentesis

pleural effusion

point-of-care ultrasound